Literature DB >> 29319093

Nutriosomes: prebiotic delivery systems combining phospholipids, a soluble dextrin and curcumin to counteract intestinal oxidative stress and inflammation.

Ana Catalán-Latorre1, Maria Pleguezuelos-Villa, Ines Castangia, Maria Letizia Manca, Carla Caddeo, Amparo Nácher, Octavio Díez-Sales, José Esteban Peris, Ramon Pons, Elvira Escribano-Ferrer, Anna Maria Fadda, Maria Manconi.   

Abstract

Nutriosomes, new phospholipid nanovesicles specifically designed for intestinal protection were developed by simultaneously loading a water-soluble dextrin (Nutriose® FM06) and a natural antioxidant (curcumin). Nutriosomes were easily fabricated in a one-step, organic solvent-free procedure. The stability and delivery performances of the vesicles were improved by adding hydroxypropyl methylcellulose. All the vesicles were small in size (mean diameter ∼168 nm), negatively charged (zeta potential ∼-38 mV, irrespective of their composition), and self-assembled predominantly in unilamellar vesicles stabilized by the presence of Nutriose®, which was located in both the inter-lamellar and inter-vesicle media, as confirmed by cryo-TEM and SAXS investigation. The dextrin acted also as a cryo-protector, avoiding vesicle collapse during the lyophilization process, and as a protector against high ionic strength and pH changes encountered in the gastrointestinal environment. Thanks to the antioxidant properties of curcumin, nutriosomes provided an optimal protective effect against hydrogen peroxide-induced oxidative stress in Caco-2 cells. Moreover, these innovative vesicles showed promising efficacy in vivo, as they improved the bioavailability and the biodistribution of both curcumin and dextrin upon oral administration, which acted synergically in reducing colonic damage chemically induced in rats.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29319093     DOI: 10.1039/c7nr05929a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  5 in total

1.  Antimalarial Activity of Orally Administered Curcumin Incorporated in Eudragit®-Containing Liposomes.

Authors:  Elisabet Martí Coma-Cros; Arnau Biosca; Elena Lantero; Maria Letizia Manca; Carla Caddeo; Lucía Gutiérrez; Miriam Ramírez; Livia Neves Borgheti-Cardoso; Maria Manconi; Xavier Fernàndez-Busquets
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

2.  Mouthwash Formulation Co-Delivering Quercetin and Mint Oil in Liposomes Improved with Glycol and Ethanol and Tailored for Protecting and Tackling Oral Cavity.

Authors:  Ines Castangia; Maria Manconi; Mohamad Allaw; Matteo Perra; Germano Orrù; Sara Fais; Alessandra Scano; Elvira Escribano-Ferrer; Mansureh Ghavam; Maryam Rezvani; Maria Letizia Manca
Journal:  Antioxidants (Basel)       Date:  2022-02-11

3.  Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease.

Authors:  Pathik Parekh; Marcello Serra; Mohamad Allaw; Matteo Perra; Jacopo Marongiu; Giulia Tolle; Annalisa Pinna; Maria Antonietta Casu; Maria Manconi; Pierluigi Caboni; Olivier J J Manzoni; Micaela Morelli
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

4.  From waste to health: sustainable exploitation of grape pomace seed extract to manufacture antioxidant, regenerative and prebiotic nanovesicles within circular economy.

Authors:  Maria Letizia Manca; Eleonora Casula; Francesca Marongiu; Gianluigi Bacchetta; Giorgia Sarais; Marco Zaru; Elvira Escribano-Ferrer; José Esteban Peris; Iris Usach; Sara Fais; Alessandra Scano; Germano Orrù; Richard G Maroun; Anna Maria Fadda; Maria Manconi
Journal:  Sci Rep       Date:  2020-08-25       Impact factor: 4.379

Review 5.  Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases.

Authors:  Cristina Quispe; Natália Cruz-Martins; Maria Letizia Manca; Maria Manconi; Oksana Sytar; Nataliia Hudz; Mariia Shanaida; Manoj Kumar; Yasaman Taheri; Miquel Martorell; Javad Sharifi-Rad; Gianfranco Pintus; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-09-15       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.